Luminicell is a Singapore-based biotechnology company that specializes in advanced biocompatible fluorescent probes for long-term live cell, deep-tissue bio-imaging and diagnostics applications with exceptional sensitivity.

Founded in 2014, Luminicell manufactures fluorescent lipid nanoparticles with its patented encapsulation platform technology, combining it with novel Aggregation-Induced Emission (AIE) molecular powering its next-generation, ultra-bright fluorescent AIEdot™ trackers. AIEdots exhibit outstanding photostability, enabling continuous monitoring of biological processes and unlocking long-term imaging for both in vitro and in vivo applications.

Luminicell is a wholly owned subsidiary of Nanolumi.